| Literature DB >> 33539997 |
Mengsuo Cui1, Hao Pan2, Dongyang Fang1, Haowei Sun3, Sen Qiao1, Weisan Pan4.
Abstract
Patient responses to doses vary widely, and affording limited doses to such a diverse population will inevitably yield unsatisfactory therapeutic effects and even adverse effects. In Particular, there is an urgent demand for a dynamic dose-control platform for pediatric patients, many of whom require diverse doses and flexible dose adjustments. The aim of this study was to explore the possibility of using a drop-on-powder (DoP) technology-based desktop 3D printer to build a dynamic dose-control platform for theophylline (TP) and metoprolol tartrate (MT). In addition, the impact of drug loading patterns on the accuracy of dose regulation was also assessed. All of the printed tablets exhibited good mechanical properties and satisfactory structural integrity. On printing tablets with target drug doses, the accuracy was in the range of 91.2~108% with a small variation coefficient in the range of 0.5~3.2%. Compared with traditional divided-dose methods, drop-on-powder 3D printing technology exhibited higher accuracy in dose regulation, but had less impact on the in vitro drug release behavior. The results in this work clearly indicate the possibility and ability of DoP technology as a promising method for constructing a dynamic dose-control platform for the fabrication of personalized medicines for pediatric patients.Entities:
Keywords: Drop-on-powder 3D printing technology (DoP); Dynamic dose-control platform; Metoprolol tartrate (MT); Pediatric patient; Personalized medicines; Theophylline (TP)
Mesh:
Substances:
Year: 2021 PMID: 33539997 DOI: 10.1016/j.ijpharm.2021.120201
Source DB: PubMed Journal: Int J Pharm ISSN: 0378-5173 Impact factor: 5.875